Canton, OHNCT07036133Now EnrollingIRB Ready

Advanced Solid Tumors Clinical Trial in Canton, OH

Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Canton. Study-provided care at no cost to qualified participants.

Sponsored by Acrotech Biopharma Inc.

Quick Self-Assessment

See if you qualify for this Canton location

Preparing your pre-screening questions…

Expert Care in Canton

Access advanced solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related advanced solid tumors treatment provided free

Apply for This Canton Location

Check if you qualify for this advanced solid tumors clinical trial in Canton, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Canton

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Canton site if eligible
  4. 4Begin participation

About This Advanced Solid Tumors Study in Canton

This purpose of this study is to help to evaluate the pharmacokinetic (PK) profile of pralatrexate when administered to patients with various degrees of hepatic impairment and to evaluate the safety and establish the dosing recommendations for pralatrexate administered once weekly for 6 weeks of every 7-week treatment cycle in patients with hepatic impairment. Pharmacokinetics (or PK) is the study of how your body absorbs, breaks down, and removes a study drug.

Sponsor: Acrotech Biopharma Inc.

Who Can Participate

Inclusion Criteria

Patient must be willing and capable of giving written Informed Consent and must be able to adhere to dosing and visit schedules as well as meet all study requirements
Patient is diagnosed with advanced solid tumor or hematological malignancy.
Patient is at least 18 years of age and has a life expectancy of at least 6 months.
Patient has normal or abnormal hepatic function as defined by normal, mild (Child-Pugh A), moderate (Child-Pugh B ), or severe (Child-Pugh C) liver impairment
Patient has adequate hematologic and renal function as defined by: Absolute neutrophil count (ANC) ≥1000/μL Platelet count ≥100,000/μL Creatinine ≤ 1.5 mg/dL or calculated creatinine clearance ≥50 mL/min
Patient has an Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2.
Patient is willing to practice 2 forms of contraception, one of which must be a barrier method, from study entry until at least 30 days after the last dose of pralatrexate
Females of childbearing potential must have a negative pregnancy test within 30 days prior to enrollment. Females who are postmenopausal for at least 1 year (defined as more than 12 months since last menses) or who are surgically sterilized do not require this test.

Exclusion Criteria

Patient has had previous exposure to pralatrexate
Patient has used any investigational drugs, biologics, or devices within 30 days prior to study treatment or plans to use any of these during the course of the study.
Patient has an active, uncontrolled infection, underlying medical condition, or other serious illness that would impair the patient's ability to receive the protocol-defined treatment.
Patient has known or suspected intolerance or hypersensitivity to the investigational product or any related compound.
Patient has congestive heart failure at Class III/IV according to the New York Heart Association (NYHA) Functional Classification
Patient has had major surgery within 30 days prior to enrollment.
Patient with central nervous system (CNS) metastases
Patient is pregnant or breast-feeding.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Canton?

Yes, this clinical trial (NCT07036133) has an active research site in Canton, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Advanced Solid Tumors Treatment Options in Canton, OH

If you're searching for advanced solid tumors treatment options in Canton, OH, this clinical trial (NCT07036133) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Canton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all advanced solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Canton, OH

See all advanced solid tumors clinical trials recruiting in Canton — not just this study.

Browse Advanced Solid Tumors Trials in Canton →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAlzheimers Disease TrialsAtopic Dermatitis TrialsErectile Dysfunction TrialsAll Conditions →

Ready to Join in Canton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Canton, OH